Cargando…
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
With the emergence and rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants, escaping vaccine-induced immunity is a concern. Three vaccination schedules, homologous or heterologous, have been initially applied due to an insufficient supply of vaccin...
Autores principales: | Choi, Ju-yeon, Lee, Young Jae, Ko, Jae-Hoon, Kim, Su-Hwan, Kim, Hye-Jin, Lee, Hye Won, Jeong, Hyeonji, Kim, Tae-Yong, Jang, Yeong Gyeong, Hong, Hyo-jeong, Kim, Min-Seong, Lee, Sang Eun, Kim, Yong Guan, Chung, Eun Joo, Lim, Heeji, Jang, Sundong, Kim, Kwangwook, Kim, Sung Soon, Ahn, Jin Young, Choi, Jun Yong, Kim, Yong Chan, Park, Yoon Soo, Peck, Kyong Ran, Kim, Byoungguk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309354/ https://www.ncbi.nlm.nih.gov/pubmed/35899050 http://dx.doi.org/10.3389/fcimb.2022.948014 |
Ejemplares similares
-
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity
por: Bae, Seongman, et al.
Publicado: (2022) -
A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen
por: Baek, Yae Jee, et al.
Publicado: (2023) -
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea
por: Lim, Heeji, et al.
Publicado: (2023) -
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022
por: Lee, Young Jae, et al.
Publicado: (2023) -
Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea
por: Ahn, Jin Young, et al.
Publicado: (2023)